Investing.com - Merck&Co reported on Thursday second quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Merck&Co announced earnings per share of $1.87 on revenue of $14.59B. Analysts polled by Investing.com anticipated EPS of $1.68 on revenue of $13.83B.
Merck&Co shares are up 19% from the beginning of the year, still down 4.69% from its 52 week high of $95.72 set on June 27. They are outperforming the S&P 500 which is down 15.58% from the start of the year.
Merck&Co follows other major Healthcare sector earnings this month
Merck&Co's report follows an earnings beat by UnitedHealth on July 15, who reported EPS of $5.57 on revenue of $80.33B, compared to forecasts EPS of $5.21 on revenue of $79.68B.
J&J had beat expectations on July 19 with second quarter EPS of $2.59 on revenue of $24.02B, compared to forecast for EPS of $2.54 on revenue of $23.77B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar